Dr. Christopher R. Cole, MD

Dr. Cole practices at Parkview Medical Center Inc - Anticoagulation Clinic - HOPD in Pueblo, Colorado.

Dr. Cole's NPI, 1457348468, was assigned on October 4, 2005. Dr. Cole graduated from West Virginia University School Of Medicine in 1992. Dr. Cole holds Colorado license 40306.

Dr. Cole's primary practice is Parkview Medical Center Inc - Anticoagulation Clinic - HOPD, at 54 Club Manor Dr 101, Pueblo, CO 81008.

Dr. Cole's primary practice is Parkview Medical Center Inc - Anticoagulation Clinic - HOPD in Pueblo, Colorado. Dr. Cole is also affiliated with CommonSpirit - Penrose Hospital. The medical group on file is Colorado Springs Cardiology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cole practices, 2 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Cole's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. Cole is board certified in clinical cardiac electrophysiology by the American Board of Internal Medicine. Dmand AI has Dr. Cole's licenses on file in 3 states: Colorado, Kansas and Ohio.

Dmand AI lists aneurysm, aortic atherosclerois, arterial blot clot /embolism, atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Cole treats.

CMS data shows 3,443 Medicare services from Dr. Cole across 25 procedure codes in 2024, for 1,129 Medicare patients. Medicare paid $168,043 for them.

CMS counts 1,129 Medicare patients who saw Dr. Cole in 2024. The largest group is 65 to 74, with 446 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cole's median patient age at 78, with 37% women.

In 2024, Dr. Cole wrote 2,064 Medicare Part D claims for 481 patients. 72% of them were for generic drugs. CMS names the drug for 1,911 of them, across 27 drugs with 11 or more claims each, at $790,314 in total drug cost. In 2023, CMS named 1,554 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 24 out of 100 for Dr. Cole for performance year 2024, reported individually.

Dmand AI links 15 papers to Dr. Cole in 2003. The most frequent topics are Catheter Ablation, Exercise Test and Electrophysiologic Techniques, Cardiac. Dr. Cole has published most often in Pacing Clin Electrophysiol. Dr. Cole's most frequent co-authors are Andrea Natale, MD, Thomas J. Dresing, MD and Stuart Welsh Adler, MD.

Dmand AI links Dr. Cole to 7 clinical trials. 3 are still active or recruiting. Conditions studied include Atrial Fibrillation, Heart Failure and Arrhythmias, Cardiac. Boston Scientific Corporation sponsors the most, 3.

CMS Open Payments shows 228 general payments to Dr. Cole from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. Pfizer Inc. paid the most, $2,849.

Dmand AI lists 2 awards for Dr. Cole, most recently CMS Stage 1 EHR in 2013.

Dr. Cole graduated from West Virginia University School Of Medicine in 1992. Dr. Cole is a member of ACC.

Dr. Cole is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.